XML 114 R103.htm IDEA: XBRL DOCUMENT v3.25.3
Note 21 - Fair Value of Financial Instruments - Reconciliation of the Fair Value (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Balance $ 3,148 $ 2,691 $ 3,148 $ 2,691
Liabilities, balance 4,308 3,375 4,308 3,375
Issuance of seller phantom equity awards in connection with acquisition 4,308 3,375 4,308 3,375
Contingent Consideration Liability [Member]        
Included in other comprehensive income 0 0 0 0
Liabilities, balance 0 3,375 2,725 3,105
Issuance of contingent consideration in connection with acquisitions 980 0 980 0
Settlements of contingent consideration liabilities 0 0 (2,725) 0
Included in net income, liability 0 0 0 270
Liabilities, balance 980 3,375 980 3,375
Issuance of seller phantom equity awards in connection with acquisition 980 3,375 980 3,375
Seller Phantom Equity Award [Member]        
Liabilities, balance 0 0 0 0
Liabilities, balance 3,328 0 3,328 0
Issuance of seller phantom equity awards in connection with acquisition 3,328 0 3,328 0
Equity Method Investments [Member] | Limited Liability Investments [Member]        
Balance 3,037 2,908 2,859 3,496
Distributions received (34) (1,186) (129) (2,238)
Included in net loss 111 95 289 173
Balance 3,148 2,691 3,148 2,691
Included in other comprehensive income 0 0 0 0
Equity Method Investments [Member] | Limited Liability Investments [Member] | Realized Investment Gains (Losses) [Member]        
Included in net loss 34 874 129 1,260
Equity Method Investments [Member] | Limited Liability Investments [Member] | Gain (Loss) On Change In Fair Value Of Limited Liability Investments At Fair Value [Member]        
Included in net loss $ 111 $ 95 $ 289 $ 173